These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. Cooke CL, Huff JL, Solnick JV. FEMS Immunol Med Microbiol; 2005 Jul 01; 45(1):11-23. PubMed ID: 15949928 [Abstract] [Full Text] [Related]
5. [The gastric mucosal injury induced by the immune responses against Helicobacter pylori]. Itoh F, Yoshimoto M, Sugawara N, Imai K. Nihon Rinsho; 2002 Feb 01; 60 Suppl 2():149-53. PubMed ID: 11979768 [No Abstract] [Full Text] [Related]
6. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A. Immunol Invest; 2007 Feb 01; 36(4):371-86. PubMed ID: 17691020 [Abstract] [Full Text] [Related]
7. Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with Helicobacter immunity and infection. Blanchard TG, Nedrud JG, Reardon ES, Czinn SJ. J Infect Dis; 1999 Mar 01; 179(3):725-8. PubMed ID: 9952387 [Abstract] [Full Text] [Related]
8. Gleanings on Helicobacter pylori infection, antigenic profile of strains, host's immune response. Figura N. Ital J Gastroenterol Hepatol; 1998 Feb 01; 30(1):40-2. PubMed ID: 9615263 [No Abstract] [Full Text] [Related]
9. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes. Luzza F, Maletta M, Imeneo M, Marcheggiano A, Biancone L, Pallone F. Ital J Gastroenterol Hepatol; 1998 Feb 01; 30(1):36-9. PubMed ID: 9615262 [Abstract] [Full Text] [Related]
10. [Current progress in the development of prophylactic and therapeutic vaccination against H. pylori infection]. Nishizono A. Nihon Rinsho; 2002 Feb 01; 60 Suppl 2():745-50. PubMed ID: 11979882 [No Abstract] [Full Text] [Related]
11. Characterisation of serum and mucosal antibodies against Helicobacter pylori. McBride PD, Prach AT, Senior BW, Murray FE, Kerr MA. Biochem Soc Trans; 1997 May 01; 25(2):334S. PubMed ID: 9191379 [No Abstract] [Full Text] [Related]
13. Inflammation, immunity, and vaccines for Helicobacter pylori. D'Elios MM, Andersen LP. Helicobacter; 2009 Sep 01; 14 Suppl 1():21-8. PubMed ID: 19712164 [Abstract] [Full Text] [Related]
14. Host response and vaccine development to Helicobacter pylori infection. Blanchard TG, Czinn SJ, Nedrud JG. Curr Top Microbiol Immunol; 1999 Sep 01; 241():181-213. PubMed ID: 10087662 [Abstract] [Full Text] [Related]
15. [Helicobacter pylori: the local IgA response of the gastric mucosa]. Opferkuch W, Birkholz S. Dtsch Med Wochenschr; 1992 Oct 23; 117(43):1661. PubMed ID: 1425270 [No Abstract] [Full Text] [Related]
16. Experimental model of Helicobacter pylori infection. Del Giudice G, Ghiara P, Rappuoli R. Ital J Gastroenterol Hepatol; 1998 Oct 23; 30 Suppl 3():S261-3. PubMed ID: 10077750 [Abstract] [Full Text] [Related]
17. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Matsumoto Y, Blanchard TG, Drakes ML, Basu M, Redline RW, Levine AD, Czinn SJ. Helicobacter; 2005 Oct 23; 10(5):407-15. PubMed ID: 16181351 [Abstract] [Full Text] [Related]
18. Inflammation, immunity, and vaccines for Helicobacter infection. Permin H, Andersen LP. Helicobacter; 2005 Oct 23; 10 Suppl 1():21-5. PubMed ID: 16178967 [Abstract] [Full Text] [Related]
19. Interactions between Helicobacter pylori and the local mucosal immune system. Ernst PB, Pecquet S. Scand J Gastroenterol Suppl; 1991 Oct 23; 187():56-64. PubMed ID: 1775925 [Abstract] [Full Text] [Related]
20. [Immune and inflammatory reaction to Helicobacter pylori in the stomach]. Wakatsuki Y. Nihon Rinsho; 2005 Nov 23; 63 Suppl 11():150-5. PubMed ID: 16363522 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]